Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
API Review
>>
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
>> article
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
Editor:xuezhe Clicks:
0
Date:2023-8-11 15:27:56
Keyword:
macrolides
Healthoo Information:
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Indian import volumes of Macrolides in Jan. 2021
Import volumes of Macrolides APIs in India in Jul 2020
Macrolides drugs rank in sample drugstores in March 2020
Macrolides export volumes in Jan-Sep 2018
Macrolides export average prices in 2015-2018 (Jan-Sep)
Macrolides export volumes in 2015-2018 (Jan-Sep)
Macrolides drugs rank in sample drugstores in June 2018
Macrolides drugs rank in sample drugstores in Mar 2018
Macrolides drugs rank in sample drugstores in Sep 2017
Macrolides domestic price trend in 2017
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
